Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04416204 · ClinicalTrials.gov registry record · NA

Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT04416204: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT04416204 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04416204, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

The experimental approach in this study intends to investigate the role of hepatic glycogen content on nocturnal regulation of endogenous glucose production including the relative contributions of glycogenolysis and gluconeogenesis and the extent to which this differs between subjects with type 2 diabetes and subjects without diabetes. Both participants with type 2 diabetes and participants without diabetes will be studied after consuming either a low carbohydrate (no glycogen loading) or high carbohydrate (glycogen loading) diet.

Primary Outcome

We measured the rates and contribution of Gluconeogenesis (GNG) to nocturnal Endogenous Glucose Production (EGP) using the deuterated water technique after either glycogen loading or no glycogen loading in subjects with type 2 diabetes.

Interventions

  • OTHER glycogen loading
  • OTHER No Glycogen Loading

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2020-08-21
Est. Completion 2023-02-15
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT04416204 record still lists

NCT04416204 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which glycogen loading is the first listed.

NCT04416204 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04416204 about?

NCT04416204 is a clinical study titled "Effect of High Carbohydrate vs. Low Carbohydrate Diet in Type 2 Diabetes". The experimental approach in this study intends to investigate the role of hepatic glycogen content on nocturnal regulation of endogenous glucose production including the relative contributions of glycogenolysis and gluconeogenesis and the extent to which this differs between subjects with type 2 di...

What is the current status of trial NCT04416204?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-08-21. Estimated completion is 2023-02-15.

What interventions are being tested in trial NCT04416204?

The interventions under investigation include: glycogen loading (OTHER), No Glycogen Loading (OTHER).

Who is sponsoring clinical trial NCT04416204?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04416204's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04416204, the US trial registry maintained by the National Library of Medicine. NCT04416204 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.